$SPRY

$3.92 -$0.11 (2.73%) Close

$SPRY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 99.4M shares outstanding

Who owns SPRY?

By type of holder

Institutions 91.1% Insiders 9.0% Everyone else 0.0%

Concentration Top 10 holders own 132.2%

Lowenthal Richard E 28.9% · Tanimoto Sarina 28.2%

Institutional ownership

91.1%

-3.6 pts vs last qtr

Institutional holders

207

+4 vs last qtr

Net shares bought

−3.6M

by institutions in Q2 2026

New / sold out

38 / 34

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Capital World Investors NEW +2.8M
Tyro Capital Management LLC +1.5M

Biggest sellers in Q2 2026

Millennium Management LLC −3.6M
Franklin Resources Inc SOLD OUT −3.3M

Who is planning to sell?

Notices of proposed sale, last 12 months

$6.07M

21 notices from 7 people

Shares covered

994.4K

1.00% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Eric Karas Officer $1.59M
Richard Lowenthal Officer $1.51M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+241.4%

+35.93% a year

Each share's claim on the business

−70.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $54.5M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years30% 3–5 years28% 1–3 years20% Under 1 year22%

Quarterly turnover

13.6%

of institutional shares changed hands

Top 10 managers, median time held

3.5 years

Super Investors

Investment managers reporting SPRY on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RC Ra Capital Management, L.P. 13D · 11.1%	10.9M	10.92%	Unchanged	2022	0.8%
Shares held by quarter Peak holding10.9M (Q3'24) Change over 8 quarters0 Share of the company10.920% Disclosed stake13D · 11.1% Ra Capital Management, L.P.'s full portfolio →
RC Rubric Capital Management LP	8.5M	8.59%	+540.9K (+6.8%)	2025	0.6%
Shares held by quarter Peak holding8.5M (Q2'26) Change over 8 quarters+8.5M Share of the company8.590% Rubric Capital Management LP's full portfolio →

Ra Capital Management, L.P.

13D · 11.1%

10.9M

% of company

10.92%

Change vs last qtr

Unchanged

Held since

2022

Rubric Capital Management LP

8.5M

% of company

8.59%

Change vs last qtr

+540.9K (+6.8%)

Held since

2025

28 more super investors behind a free account

See every manager holding ARS Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting SPRY on Form N-PORT; together they hold 20.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SW SMALLCAP World Fund Inc SMALLCAP World Fund Inc	$21.5M	2.7M	2.70%	0.02%	June 30, 2026
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$18.3M	2.3M	2.30%	0.17%	June 30, 2026

SMALLCAP World Fund Inc

Position value

$21.5M

% of company

2.70%

% of the fund

0.02%

As of

June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$18.3M

% of company

2.30%

% of the fund

0.17%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding ARS Pharmaceuticals, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LR Lowenthal Richard E Insider	28.8M	28.93%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company28.930% Lowenthal Richard E's insider activity →
TS Tanimoto Sarina Insider	28.0M	28.19%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company28.190% Tanimoto Sarina's insider activity →

Lowenthal Richard E

Insider

28.8M

% of company

28.93%

Change vs last qtr

—

Held since

—

Tanimoto Sarina

Insider

28.0M

% of company

28.19%

Change vs last qtr

—

Held since

—

14 more holders behind a free account

See every insider and 5%+ holder of ARS Pharmaceuticals, Inc..

Comments